Join

Compare · RXST vs STAA

RXST vs STAA

Side-by-side comparison of RxSight Inc. (RXST) and STAAR Surgical Company (STAA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both RXST and STAA operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
  • STAA is the larger of the two at $1.41B, about 7.1x RXST ($198.3M).
  • STAA has been more active in the news (10 items in the past 4 weeks vs 2 for RXST).
  • Both have 25 recent analyst ratings on file.
MetricRXSTSTAA
Company
RxSight Inc.
STAAR Surgical Company
Price
$4.77-3.25%
$28.22-0.98%
Market cap
$198.3M
$1.41B
1M return
-
+3.37%
1Y return
-
+69.03%
Industry
Ophthalmic Goods
Ophthalmic Goods
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
2
10
Recent ratings
25
25
RXST

RxSight Inc.

RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.

STAA

STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Latest RXST

Latest STAA